Clinical aspects of uterine papillary serous carcinoma
- PMID: 18197002
- DOI: 10.1097/GCO.0b013e3282f2b10d
Clinical aspects of uterine papillary serous carcinoma
Abstract
Purpose of review: We review the demographic and clinicopathologic characteristics, and prognosis of women diagnosed with uterine papillary serous carcinoma, with a focus on clinical management.
Recent findings: Pathologic evaluation of postmenopausal bleeding is preferred for patients who fit the profile of a high-risk endometrial cancer such as uterine papillary serous carcinoma. Women diagnosed with endometrial cancer who fit this profile and all women with uterine papillary serous carcinoma should undergo comprehensive surgical staging and aggressive cytoreduction of extrauterine disease. Adjuvant therapy remains controversial. Several recent investigations reported on the potential benefit of adjuvant chemotherapy, with many recommending additional loco-regional radiation.
Summary: Despite the lack of randomized trials on uterine papillary serous carcinoma, several recent reports have provided insight into the diagnosis, surgical management, and adjuvant treatment of this high-risk endometrial cancer.
Similar articles
-
The management of serous papillary uterine cancer.Curr Opin Oncol. 2006 Sep;18(5):494-9. doi: 10.1097/01.cco.0000239890.36408.75. Curr Opin Oncol. 2006. PMID: 16894299 Review.
-
Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.Gynecol Oncol. 2009 Nov;115(2):249-56. doi: 10.1016/j.ygyno.2009.07.004. Epub 2009 Aug 18. Gynecol Oncol. 2009. PMID: 19692115
-
Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.Curr Opin Obstet Gynecol. 2010 Feb;22(1):21-9. doi: 10.1097/GCO.0b013e328334d8a3. Curr Opin Obstet Gynecol. 2010. PMID: 19952744 Review.
-
Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases.Diagn Gynecol Obstet. 1982 Winter;4(4):261-7. Diagn Gynecol Obstet. 1982. PMID: 6891917
-
[Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].Zhonghua Fu Chan Ke Za Zhi. 2006 Dec;41(12):817-21. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 17327111 Chinese.
Cited by
-
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.Virchows Arch. 2012 Sep;461(3):291-8. doi: 10.1007/s00428-012-1275-2. Epub 2012 Jul 24. Virchows Arch. 2012. PMID: 22824999 Free PMC article.
-
Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma.Gynecol Oncol. 2012 Jan;124(1):21-5. doi: 10.1016/j.ygyno.2011.10.007. Epub 2011 Oct 27. Gynecol Oncol. 2012. PMID: 22035806 Free PMC article. Clinical Trial.
-
The genomics and genetics of endometrial cancer.Adv Genomics Genet. 2012 Mar;2012(2):33-47. doi: 10.2147/AGG.S28953. Adv Genomics Genet. 2012. PMID: 22888282 Free PMC article.
-
Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.J Natl Cancer Inst. 2015 Sep 1;107(11):djv249. doi: 10.1093/jnci/djv249. Print 2015 Nov. J Natl Cancer Inst. 2015. PMID: 26330387 Free PMC article.
-
Metastatic gynecologic malignancies: advances in treatment and management.Clin Exp Metastasis. 2018 Aug;35(5-6):521-533. doi: 10.1007/s10585-018-9889-7. Epub 2018 Jun 21. Clin Exp Metastasis. 2018. PMID: 29931499 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials